Back to Search
HEINZ-JOSEF LENZ, M.D.
M.D.
Medical Oncology Physician
NPI: 1700814209IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
A63854(CA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
A63854(CA)
Education
OTHER
Class of 1985
Research & Publications (20)
Colon cancer stem cells: a new target in the war against cancer.
PMID 19259287·Gastrointest Cancer Res·2008
8-other
Accomplishments in 2007 in biologic markers for gastrointestinal cancers.
PMID 19352470·Gastrointest Cancer Res·2008
8-other
KRAS mutation in metastatic colorectal cancer and its impact on the use of EGFR inhibitors.
PMID 19378369·Clin Adv Hematol Oncol·2008
8-other
First-line combination treatment of colorectal cancer with hepatic metastases: choosing a targeted agent.
PMID 19101405·Cancer Treat Rev·2008
5-case
Prognostic/Predictive molecular markers in colorectal cancer.
PMID 19360143·Gastrointest Cancer Res·2007
8-other
Management and preparedness for infusion and hypersensitivity reactions.
PMID 17522249·Oncologist·2007
6-review
Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.
PMID 17133415·Cancer·2007
4-observational
Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines.
PMID 17050875·J Clin Oncol·2006
3-trial
Anti-EGFR mechanism of action: antitumor effect and underlying cause of adverse events.
PMID 16736978·Oncology (Williston Park)·2006
6-review
Angiogenesis as a target in colorectal cancer therapy. Introduction.
PMID 15696023·Semin Oncol·2004
7-preclinical
Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic to liver.
PMID 12215272·Hum Gene Ther·2002
7-preclinical
Genetic variations in angiogenesis pathway genes associated with clinical outcome in localized gastric adenocarcinoma.
PMID 19622587·Ann Oncol·2010
4-observational
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.
PMID 19536776·Int J Cancer·2009
7-preclinical
The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.
PMID 19561607·Nat Genet·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1441 EASTLAKE AVE, NOR 8302E
LOS ANGELES, CA 90033 - Phone
- (323) 865-3105
Quick Facts
- NPI
- 1700814209
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 41
- Publications
- 20
Are you this provider?
Claim Your Profile